SCHULTZ PETER G has a total of 15 patent applications. Its first patent ever was published in 2003. It filed its patents most often in United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets biotechnology, pharmaceuticals and organic fine chemistry are CHEVREUX BASTIEN, NSC TECHNOLOGIES LLC and INST BELKA AKAD NAUK SSSR.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 11 | |
#2 | WIPO (World Intellectual Property Organization) | 4 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Fermentation | |
#2 | Microorganisms | |
#3 | Therapeutic chemical compounds | |
#4 | Peptides | |
#5 | Heterocyclic compounds | |
#6 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Schultz Peter G | 15 |
#2 | Wang Lei | 11 |
#3 | Zhang Zhiwen | 8 |
#4 | Pastrnak Miro | 7 |
#5 | Meggers Eric L | 7 |
#6 | Anderson John Christopher | 7 |
#7 | Liu David R | 7 |
#8 | Magliery Thomas J | 7 |
#9 | Mehl Ryan Aaron | 6 |
#10 | Santoro Stephen William | 6 |
Publication | Filing date | Title |
---|---|---|
WO2010056907A2 | Heterocyclic compounds that induce pancreatic beta-cell expansion |